Jeffrey W Bird - Net Worth and Insider Trading

Jeffrey W Bird Net Worth

The estimated net worth of Jeffrey W Bird is at least $751 Million dollars as of 2024-11-29. Jeffrey W Bird is the Director of Forty Seven Inc and owns about 3,876,666 shares of Forty Seven Inc (FTSV) stock worth over $370 Million. Jeffrey W Bird is the Director of Horizon Therapeutics PLC and owns about 3,028,304 shares of Horizon Therapeutics PLC (HZNP) stock worth over $352 Million. Jeffrey W Bird is also the Director of Portola Pharmaceuticals Inc and owns about 1,425,065 shares of Portola Pharmaceuticals Inc (PTLA) stock worth over $26 Million. Besides these, Jeffrey W Bird also holds Mattersight Corp (MATR) , Molecular Templates Inc (MTEM) . Details can be seen in Jeffrey W Bird's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey W Bird has not made any transactions after 2019-07-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Jeffrey W Bird

Jeffrey W Bird Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeffrey W Bird owns 11 companies in total, including Portola Pharmaceuticals Inc (PTLA) , Forty Seven Inc (FTSV) , and Venus Concept Inc (VERO) among others .

Click here to see the complete history of Jeffrey W Bird’s form 4 insider trades.

Insider Ownership Summary of Jeffrey W Bird

Ticker	Comapny	Transaction Date	Type of Owner
PTLA	Portola Pharmaceuticals Inc	2020-07-02	director
FTSV	Forty Seven Inc	2020-04-07	director
VERO	Venus Concept Inc	2018-06-13	director
		2015-10-06	10 percent owner
		2017-04-12	10 percent owner
		2017-06-01	10 percent owner
		2017-06-01	10 percent owner
		2013-12-13	director
		2013-03-20	10 percent owner
		2009-10-16	10 percent owner
		2010-02-10	10 percent owner

Jeffrey W Bird Latest Holdings Summary

Jeffrey W Bird currently owns a total of 5 stocks. Among these stocks, Jeffrey W Bird owns 3,876,666 shares of Forty Seven Inc (FTSV) as of July 22, 2019, with a value of $370 Million and a weighting of 49.27%. Jeffrey W Bird owns 3,028,304 shares of Horizon Therapeutics PLC (HZNP) as of December 13, 2013, with a value of $352 Million and a weighting of 46.87%. Jeffrey W Bird also owns 1,425,065 shares of Portola Pharmaceuticals Inc (PTLA) as of August 23, 2018, with a value of $26 Million and a weighting of 3.42%. The other 2 stocks Mattersight Corp (MATR) , Molecular Templates Inc (MTEM) have a combined weighting of 0.44% among all his current holdings.

Latest Holdings of Jeffrey W Bird

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
FTSV	Forty Seven Inc	2019-07-22	3,876,666	95.51	370,260,370
HZNP	Horizon Therapeutics PLC	2013-12-13	3,028,304	116.30	352,191,755
PTLA	Portola Pharmaceuticals Inc	2018-08-23	1,425,065	18.03	25,693,922
MATR	Mattersight Corp	2017-06-01	1,236,591	2.68	3,307,881
MTEM	Molecular Templates Inc	2017-06-01	26,177	0.37	9,801

Holding Weightings of Jeffrey W Bird

Jeffrey W Bird Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeffrey W Bird has made a total of 0 transactions in Forty Seven Inc (FTSV) over the past 5 years. The most-recent trade in Forty Seven Inc is the acquisition of 750,000 shares on July 22, 2019, which cost Jeffrey W Bird around $6 Million.

According to the SEC Form 4 filings, Jeffrey W Bird has made a total of 0 transactions in Horizon Therapeutics PLC (HZNP) over the past 5 years. The most-recent trade in Horizon Therapeutics PLC is the acquisition of 668,673 shares on December 13, 2013, which cost Jeffrey W Bird around $4 Million.

According to the SEC Form 4 filings, Jeffrey W Bird has made a total of 0 transactions in Portola Pharmaceuticals Inc (PTLA) over the past 5 years. The most-recent trade in Portola Pharmaceuticals Inc is the acquisition of 390,000 shares on August 23, 2018, which cost Jeffrey W Bird around $10 Million.

More details on Jeffrey W Bird's insider transactions can be found in the Insider Trading History of Jeffrey W Bird table.

Insider Trading History of Jeffrey W Bird

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeffrey W Bird Trading Performance

GuruFocus tracks the stock performance after each of Jeffrey W Bird's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey W Bird is 13.08%. GuruFocus also compares Jeffrey W Bird's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey W Bird within 3 months outperforms 9 times out of 20 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jeffrey W Bird's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jeffrey W Bird

Average Return

Average return per transaction

Outperforming Transactions

9 out of 19 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	9.63
Relative Return to S&P 500(%)	8.25

Jeffrey W Bird Ownership Network

Ownership Network List of Jeffrey W Bird

No Data

Ownership Network Relation of Jeffrey W Bird

Jeffrey W Bird Owned Company Details

What does Portola Pharmaceuticals Inc do?

Who are the key executives at Portola Pharmaceuticals Inc?

Jeffrey W Bird is the director of Portola Pharmaceuticals Inc. Other key executives at Portola Pharmaceuticals Inc include EVP & General Counsel John B Moriarty , EVP and CFO Mardi Dier , and EVP & CMO Rajiv Patni .

Portola Pharmaceuticals Inc (PTLA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Portola Pharmaceuticals Inc (PTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Portola Pharmaceuticals Inc (PTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Portola Pharmaceuticals Inc (PTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Portola Pharmaceuticals Inc Insider Transactions

No Available Data

What does Forty Seven Inc do?

Who are the key executives at Forty Seven Inc?

Jeffrey W Bird is the director of Forty Seven Inc. Other key executives at Forty Seven Inc include Chief Financial Officer Ann D Rhoads , 10 percent owner Lightspeed General Partner X, L.p. , and 10 percent owner Lightspeed Ultimate General Partner X, Ltd. .

Forty Seven Inc (FTSV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Forty Seven Inc (FTSV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Forty Seven Inc (FTSV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Forty Seven Inc (FTSV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Forty Seven Inc Insider Transactions

No Available Data

What does Venus Concept Inc do?

Who are the key executives at Venus Concept Inc?

Jeffrey W Bird is the director of Venus Concept Inc. Other key executives at Venus Concept Inc include 10 percent owner Michael Willingham Masters , President Global Sales Ross Portaro , and 10 percent owner Marlin Master Fund Offshore Ii, Lp .

Venus Concept Inc (VERO) Insider Trades Summary

Over the past 18 months, Jeffrey W Bird made no insider transaction in Venus Concept Inc (VERO). Other recent insider transactions involving Venus Concept Inc (VERO) include a net sale of 958,979 shares made by Michael Willingham Masters ,

In summary, during the past 3 months, insiders sold 469,031 shares of Venus Concept Inc (VERO) in total and bought 0 shares, with a net sale of 469,031 shares. During the past 18 months, 958,979 shares of Venus Concept Inc (VERO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 958,979 shares.

Venus Concept Inc (VERO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Venus Concept Inc Insider Transactions

No Available Data

What does Pure Storage Inc do?

Who are the key executives at Pure Storage Inc?

Jeffrey W Bird is the 10 percent owner of Pure Storage Inc. Other key executives at Pure Storage Inc include director & Chief Technology Officer John Colgrove , Chief Accounting Officer Mona Chu , and Chief Revenue Officer Dan Fitzsimons .

Pure Storage Inc (PSTG) Insider Trades Summary

Over the past 18 months, Jeffrey W Bird made no insider transaction in Pure Storage Inc (PSTG). Other recent insider transactions involving Pure Storage Inc (PSTG) include a net sale of 900,000 shares made by John Colgrove , a net sale of 79,654 shares made by Mona Chu , and a net sale of 125,164 shares made by Dan Fitzsimons .

In summary, during the past 3 months, insiders sold 654,542 shares of Pure Storage Inc (PSTG) in total and bought 0 shares, with a net sale of 654,542 shares. During the past 18 months, 1,831,435 shares of Pure Storage Inc (PSTG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,831,435 shares.

Pure Storage Inc (PSTG)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pure Storage Inc Insider Transactions

No Available Data

What does Yext Inc do?

Who are the key executives at Yext Inc?

Jeffrey W Bird is the 10 percent owner of Yext Inc. Other key executives at Yext Inc include General Counsel Ho Shin , director & President Brian Distelburger , and Chief Accounting Officer Faheem Bawa .

Yext Inc (YEXT) Insider Trades Summary

Over the past 18 months, Jeffrey W Bird made no insider transaction in Yext Inc (YEXT). Other recent insider transactions involving Yext Inc (YEXT) include a net sale of 56,000 shares made by Ho Shin , and a net purchase of 32,600 shares made by Seth H. Waugh .

In summary, during the past 3 months, insiders sold 0 shares of Yext Inc (YEXT) in total and bought 32,600 shares, with a net purchase of 32,600 shares. During the past 18 months, 56,000 shares of Yext Inc (YEXT) were sold and 32,600 shares were bought by its insiders, resulting in a net sale of 23,400 shares.

Yext Inc (YEXT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Yext Inc Insider Transactions

No Available Data

What does Mattersight Corp do?

Who are the key executives at Mattersight Corp?

Jeffrey W Bird is the 10 percent owner of Mattersight Corp. Other key executives at Mattersight Corp include director & 10 percent owner Tench Coxe , director & CFO David B Mullen , and 10 percent owner Michael L Speiser .

Mattersight Corp (MATR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Mattersight Corp (MATR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mattersight Corp (MATR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Mattersight Corp (MATR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mattersight Corp Insider Transactions

No Available Data

What does Molecular Templates Inc do?

Who are the key executives at Molecular Templates Inc?

Jeffrey W Bird is the 10 percent owner of Molecular Templates Inc. Other key executives at Molecular Templates Inc include 10 percent owner Biotech Target N V , Chief Medical Officer Maurizio Voi , and CFO & Treasurer Sean Mclennan .

Molecular Templates Inc (MTEM) Insider Trades Summary

Over the past 18 months, Jeffrey W Bird made no insider transaction in Molecular Templates Inc (MTEM). Other recent insider transactions involving Molecular Templates Inc (MTEM) include a net purchase of 3,225,499 shares made by Biotech Target N V ,

In summary, during the past 3 months, insiders sold 1,279,820 shares of Molecular Templates Inc (MTEM) in total and bought 0 shares, with a net sale of 1,279,820 shares. During the past 18 months, 1,279,820 shares of Molecular Templates Inc (MTEM) were sold and 533,688 shares were bought by its insiders, resulting in a net sale of 746,132 shares.

Molecular Templates Inc (MTEM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Molecular Templates Inc Insider Transactions

No Available Data

What does Horizon Therapeutics PLC do?

Who are the key executives at Horizon Therapeutics PLC?

Jeffrey W Bird is the director of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include EVP and Chief Business Officer Andy Pasternak , EVP & Chief Financial Officer Aaron Cox , and EVP & Chief Medical Officer Jeffrey W Sherman .

Horizon Therapeutics PLC (HZNP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Horizon Therapeutics PLC (HZNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Horizon Therapeutics PLC Insider Transactions

No Available Data

What does Dex Liquidating Co do?

Who are the key executives at Dex Liquidating Co?

Jeffrey W Bird is the 10 percent owner of Dex Liquidating Co. Other key executives at Dex Liquidating Co include other: Former Director Younger William H Jr , V.P. & Finance & CFO & Secretary Newell Robert Y Iv , and VP,Worldwide Sales & Marketing Liam Burns .

Dex Liquidating Co (DXTRQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Dex Liquidating Co (DXTRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dex Liquidating Co (DXTRQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dex Liquidating Co (DXTRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dex Liquidating Co Insider Transactions

No Available Data

What does Corcept Therapeutics Inc do?

Who are the key executives at Corcept Therapeutics Inc?

Jeffrey W Bird is the 10 percent owner of Corcept Therapeutics Inc. Other key executives at Corcept Therapeutics Inc include CHIEF FINANCIAL OFFICER Gary Charles Robb , Chief Accounting Officer Joseph Douglas Lyon , and Chief Development Officer William Guyer .

Corcept Therapeutics Inc (CORT) Insider Trades Summary

Over the past 18 months, Jeffrey W Bird made no insider transaction in Corcept Therapeutics Inc (CORT). Other recent insider transactions involving Corcept Therapeutics Inc (CORT) include a net sale of 71,411 shares made by Joseph Douglas Lyon , a net sale of 30,950 shares made by Swisher Daniel N Jr , and a net sale of 225,000 shares made by Sean Maduck .

In summary, during the past 3 months, insiders sold 47,220 shares of Corcept Therapeutics Inc (CORT) in total and bought 0 shares, with a net sale of 47,220 shares. During the past 18 months, 524,119 shares of Corcept Therapeutics Inc (CORT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 524,119 shares.

Corcept Therapeutics Inc (CORT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Corcept Therapeutics Inc Insider Transactions

No Available Data

What does QuinStreet Inc do?

Who are the key executives at QuinStreet Inc?

Jeffrey W Bird is the 10 percent owner of QuinStreet Inc. Other key executives at QuinStreet Inc include CFO Gregory Wong , director & 10 percent owner & Chief Executive Officer Douglas Valenti , and Chief Technology Officer Nina Bhanap .

QuinStreet Inc (QNST) Insider Trades Summary

Over the past 18 months, Jeffrey W Bird made no insider transaction in QuinStreet Inc (QNST). Other recent insider transactions involving QuinStreet Inc (QNST) include a net sale of 176,168 shares made by Gregory Wong , a net purchase of 12,500 shares made by Douglas Valenti , and a net sale of 60,000 shares made by Andrew T Sheehan .

In summary, during the past 3 months, insiders sold 141,771 shares of QuinStreet Inc (QNST) in total and bought 0 shares, with a net sale of 141,771 shares. During the past 18 months, 314,188 shares of QuinStreet Inc (QNST) were sold and 12,500 shares were bought by its insiders, resulting in a net sale of 301,688 shares.

QuinStreet Inc (QNST)'s detailed insider trading history can be found in Insider Trading Tracker table.

QuinStreet Inc Insider Transactions

No Available Data

Jeffrey W Bird Mailing Address

Above is the net worth, insider trading, and ownership report for Jeffrey W Bird. You might contact Jeffrey W Bird via mailing address: 755 Page Mill Rd Ste A-200, Palo Alto Ca 94304-1005.

Discussions on Jeffrey W Bird

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.